Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT05628701
Recruiting Not applicable

Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.

NCT05628701 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2017-04-04
Last updated
2022-11-29

Condition(s) studied

Ulcerative ColitisInflammatory Bowel DiseasesIleostomy - Stoma

Investigational drug(s) / intervention(s)

Ileorectal anastomosis (IRA)Ileal pouch anal anastomosis (IPAA)ileostomy

Ileorectal anastomosis (IRA): After subtotal colectomy for ulcerative colitis the patients can either keep their end ileostomy or be reconstructed with an anastomosis (connection) between the ileum and the rectal remnant (Ileorectal anastomosis(IRA))

Ileal pouch anal anastomosis (IPAA): The rectum is removed and a pouch constructed with the distal part opf the ileum which in subsequently anastomosed (connected) to the anus(Ileal pouch anal anastomosis (IPAA)).

ileostomy: no reconstruction is performed and the patient is left with his/her ileostomy

Study summary

Background There are no prospective trials comparing the two main reconstructive options after colectomy for Ulcerative colitis, ileal pouch anal anastomosis and ileorectal anastomosis. An attempt on a randomized controlled trial has been made but after receiving standardized information patients insisted on choosing operation themselves.

Methods Adult Ulcerative colitis patients subjected to colectomy eligible for both ileal pouch anastomosis and ileorectal anastomosis are asked to participate and after receiving standardized information the get to choose reconstructive method. Patients not declining reconstruction or not considered eligible for both methods will be followed as controls. The CRUISE study is a prospective, non-randomized, multi-center, controlled trial on satisfaction, QoL, function, and complications between ileal pouch anal anastomosis and ileorectal anastomosis.

Discussion Reconstruction after colectomy is a morbidity-associated as well as a resource-intensive activity with the sole purpose of enhancing function, Quality of Life and patient satisfaction. The aim of this study is to provide the best possible information on the risks and benefits of each reconstructive treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion criteria: * Patients with Ulcerative colitis (UC) aged between 18 and 60 * Scheduled for or have previously undergone subtotal colectomy and ileostomy. * Patients should have sufficient rectal compliance and controllable inflammation in the rectal using topical Mezalasin only. Exclusion criteria * Rectal inflammation of Mayo Score \>1 * Poor sphincter function, perianal disease * Uncertainty regarding UC diagnosis P * Previous colorectal cancer or severe dysplasia * Primary Sclerosing Colitis diagnosis * \>2 year since subtotal colectomy

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Sahlgrenska Univercity Hospital Gothenburg Sweden Recruiting
Linkoeping University hospital Linköping Sweden Recruiting
Karolinska University Hospital Solna Sweden Recruiting
St. Mark's Hospital London United Kingdom Recruiting

More Linkoeping University trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05628701 on ClinicalTrials.gov ↗ ← All trials in Sweden